Clinical Trial Update: Clinical Trial on Anti-inflammatory Effect of Low-Molecular Weight Heparin in Pediatric Cataract Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the anti-inflammatory effect of low-molecular-weight heparin in pediatric cataract surgery; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Iladevi Cataract and IOL Research Center | Conditions: Inflammation | Phase 4 | Status: COMPLETED